๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Considerations in the Management of Elderly Patients With Chronic Myeloid Leukemia

โœ Scribed by Karen Seiter


Book ID
119219008
Publisher
Elsevier
Year
2012
Tongue
English
Weight
390 KB
Volume
12
Category
Article
ISSN
2152-2650

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Practical management of patients with ch
โœ Francisco Cervantes; Michael Mauro ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 175 KB

## Abstract Although imatinib has been used as frontline therapy for chronic myeloid leukemia (CML) for nearly a decade, current debate is focused on the incorporation of newer tyrosine kinase inhibitors (TKIs) at diagnosis in light of recent US Food and Drug Administration approval of nilotinib an

Management of Chronic Myeloid Leukemia i
โœ Meinolf Suttorp; Louise Eckardt; Josephine Tabea Tauer; Frederic Millot ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Current Science Inc. ๐ŸŒ English โš– 203 KB
Management of Chronic Myeloid Leukemia i
โœ Meinolf Suttorp; Louise Eckardt; Josephine Tabea Tauer; Frederic Millot ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Current Science Inc. ๐ŸŒ English โš– 203 KB

Childhood chronic myelogenous leukemia (CML) is a rare malignancy, and experience with optimal treatment is very limited. Traditionally, allogeneic hematopoietic stem cell transplantation was considered the only curative treatment. Imatinib, a small-molecule inhibitor of the BCR-ABL tyrosine kinase

Management of chronic myeloid leukemia d
โœ Frank J. Strobl; Karl V. Voelkerding; Eileen P. Smith ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 48 KB ๐Ÿ‘ 2 views

We describe the successful treatment of a pregnant patient with chronic myelogenous leukemia in chronic phase by using only leukapheresis. Following 20 leukapheresis procedures initiated during the 13th week of gestation and performed over approximately 7 weeks, the patients white blood cell count d